256 related articles for article (PubMed ID: 33096920)
1. First Identification of RNA-Binding Proteins That Regulate Alternative Exons in the Dystrophin Gene.
Miro J; Bougé AL; Murauer E; Beyne E; Da Cunha D; Claustres M; Koenig M; Tuffery-Giraud S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096920
[TBL] [Abstract][Full Text] [Related]
2. Neuronal SH-SY5Y cells use the C-dystrophin promoter coupled with exon 78 skipping and display multiple patterns of alternative splicing including two intronic insertion events.
Nishida A; Minegishi M; Takeuchi A; Awano H; Niba ET; Matsuo M
Hum Genet; 2015 Sep; 134(9):993-1001. PubMed ID: 26152642
[TBL] [Abstract][Full Text] [Related]
3. Intronic Alternative Polyadenylation in the Middle of the
Rani AQM; Yamamoto T; Kawaguchi T; Maeta K; Awano H; Nishio H; Matsuo M
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443516
[TBL] [Abstract][Full Text] [Related]
4. Targeted RNA-Seq profiling of splicing pattern in the DMD gene: exons are mostly constitutively spliced in human skeletal muscle.
Bougé AL; Murauer E; Beyne E; Miro J; Varilh J; Taulan M; Koenig M; Claustres M; Tuffery-Giraud S
Sci Rep; 2017 Jan; 7():39094. PubMed ID: 28045018
[TBL] [Abstract][Full Text] [Related]
5. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.
Lee JJA; Saito T; Duddy W; Takeda S; Yokota T
Methods Mol Biol; 2018; 1828():141-150. PubMed ID: 30171539
[TBL] [Abstract][Full Text] [Related]
6. FUBP1: a new protagonist in splicing regulation of the DMD gene.
Miro J; Laaref AM; Rofidal V; Lagrafeuille R; Hem S; Thorel D; Méchin D; Mamchaoui K; Mouly V; Claustres M; Tuffery-Giraud S
Nucleic Acids Res; 2015 Feb; 43(4):2378-89. PubMed ID: 25662218
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatic and functional optimization of antisense phosphorodiamidate morpholino oligomers (PMOs) for therapeutic modulation of RNA splicing in muscle.
Popplewell LJ; Graham IR; Malerba A; Dickson G
Methods Mol Biol; 2011; 709():153-78. PubMed ID: 21194027
[TBL] [Abstract][Full Text] [Related]
8. Endogenous Multiple Exon Skipping and Back-Splicing at the DMD Mutation Hotspot.
Suzuki H; Aoki Y; Kameyama T; Saito T; Masuda S; Tanihata J; Nagata T; Mayeda A; Takeda S; Tsukahara T
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754374
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.
Nakamura A; Aoki Y; Tsoumpra M; Yokota T; Takeda S
Methods Mol Biol; 2018; 1828():151-163. PubMed ID: 30171540
[TBL] [Abstract][Full Text] [Related]
10. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
11. Exons 45-55 Skipping Using Mutation-Tailored Cocktails of Antisense Morpholinos in the DMD Gene.
Echigoya Y; Lim KRQ; Melo D; Bao B; Trieu N; Mizobe Y; Maruyama R; Mamchaoui K; Tanihata J; Aoki Y; Takeda S; Mouly V; Duddy W; Yokota T
Mol Ther; 2019 Nov; 27(11):2005-2017. PubMed ID: 31416775
[TBL] [Abstract][Full Text] [Related]
12. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
[TBL] [Abstract][Full Text] [Related]
13. The dystrophin / utrophin homologues in Drosophila and in sea urchin.
Neuman S; Kaban A; Volk T; Yaffe D; Nudel U
Gene; 2001 Jan; 263(1-2):17-29. PubMed ID: 11223239
[TBL] [Abstract][Full Text] [Related]
14. Splicing Characteristics of Dystrophin Pseudoexons and Identification of a Novel Pathogenic Intronic Variant in the
Xie Z; Tang L; Xie Z; Sun C; Shuai H; Zhou C; Liu Y; Yu M; Zheng Y; Meng L; Zhang W; Leal SM; Wang Z; Schrauwen I; Yuan Y
Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33050418
[TBL] [Abstract][Full Text] [Related]
15. Hybrid spectrin type repeats produced by exon-skipping in dystrophin.
Menhart N
Biochim Biophys Acta; 2006 Jun; 1764(6):993-9. PubMed ID: 16716778
[TBL] [Abstract][Full Text] [Related]
16. An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.
Disset A; Bourgeois CF; Benmalek N; Claustres M; Stevenin J; Tuffery-Giraud S
Hum Mol Genet; 2006 Mar; 15(6):999-1013. PubMed ID: 16461336
[TBL] [Abstract][Full Text] [Related]
17. Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells.
van Deutekom JC; Bremmer-Bout M; Janson AA; Ginjaar IB; Baas F; den Dunnen JT; van Ommen GJ
Hum Mol Genet; 2001 Jul; 10(15):1547-54. PubMed ID: 11468272
[TBL] [Abstract][Full Text] [Related]
18. Circular dystrophin RNAs consisting of exons that were skipped by alternative splicing.
Surono A; Takeshima Y; Wibawa T; Ikezawa M; Nonaka I; Matsuo M
Hum Mol Genet; 1999 Mar; 8(3):493-500. PubMed ID: 9949208
[TBL] [Abstract][Full Text] [Related]
19. Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides.
Dunckley MG; Manoharan M; Villiet P; Eperon IC; Dickson G
Hum Mol Genet; 1998 Jul; 7(7):1083-90. PubMed ID: 9618164
[TBL] [Abstract][Full Text] [Related]
20. Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.
Toh ZY; Thandar Aung-Htut M; Pinniger G; Adams AM; Krishnaswarmy S; Wong BL; Fletcher S; Wilton SD
PLoS One; 2016; 11(1):e0145620. PubMed ID: 26745801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
